دورية أكاديمية

Pipeline Embolization Device and Flow Re-Direction Endoluminal Device for Intracranial Aneurysms: A Comparative Systematic Review and Meta-Analysis Study.

التفاصيل البيبلوغرافية
العنوان: Pipeline Embolization Device and Flow Re-Direction Endoluminal Device for Intracranial Aneurysms: A Comparative Systematic Review and Meta-Analysis Study.
المؤلفون: Rashidi F; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Habibi MA; Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran., Reyhani M; School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Fallahi MS; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Arshadi MR; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Sabahi M; Department of Neurological Surgery, Pauline Braathen Neurological Center, Cleveland Clinic Florida, Weston, Florida, USA., Vakharia K; Department of Neurosurgery and Brain Repair, University of South Florida, Morsani College of Medicine, Tampa, Florida, USA., Rahimi SY; Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, Georgia, USA. Electronic address: srahimi@augusta.edu.
المصدر: World neurosurgery [World Neurosurg] 2024 Sep; Vol. 189, pp. 399-409.e18. Date of Electronic Publication: 2024 Jun 24.
نوع المنشور: Journal Article; Systematic Review; Meta-Analysis; Comparative Study; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101528275 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-8769 (Electronic) Linking ISSN: 18788750 NLM ISO Abbreviation: World Neurosurg Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York : Elsevier
مواضيع طبية MeSH: Intracranial Aneurysm*/surgery , Intracranial Aneurysm*/therapy , Embolization, Therapeutic*/instrumentation , Embolization, Therapeutic*/methods , Endovascular Procedures*/methods , Endovascular Procedures*/instrumentation, Humans ; Treatment Outcome
مستخلص: Background: When it comes to intracranial aneurysms, the quest for more effective treatments is ongoing. Flow diversion represents a growing advancement in this field. This review seeks to compare 2 variants of the endovascular flow diversion method: the Flow Re-Direction Endoluminal Device (FRED) and the Pipeline Embolization Device (PED).
Methods: A systematic review was conducted according to the PRISMA guideline using PubMed, Scopus, Web of Science, and Embase, using appropriate terms to compare PED and FRED in double-arm studies from conception until October 8th, 2023.
Results: The meta-analysis encompassed 1769 patients, with a predominance of females (75.5%), among whom 973 patients underwent FRED procedures, while 651 received PED interventions. At 6 months, complete occlusion rates were 0.62 for FRED and 0.68 for PED (P = 0.68). At 1 year and the last follow-up, no significant differences were observed between FRED and PED, respectively. Adequate occlusion rates were similar between FRED and PED (0.82 vs. 0.79, P = 0.68). FRED showed a statistically significant higher rate of good mRS scores at follow-up (1.00 vs. 0.97, P = 0.03). Hemorrhage and re-treatment rates were higher in PED (P < 0.01) without considering the rupture status of the aneurysms due to the lack of data.
Conclusions: This meta-analysis suggests comparable efficacy but different safety profiles between FRED and PED in treating intracranial aneurysms. FRED demonstrated a higher rate of good modified Rankin scores, while PED showed increased hemorrhage and re-treatment rates. Understanding these differences is crucial for informed decision-making in clinical practice.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
فهرسة مساهمة: Keywords: FRED; Flow re-direction endoluminal device; PED; Pipeline embolization device
تواريخ الأحداث: Date Created: 20240626 Date Completed: 20240910 Latest Revision: 20240910
رمز التحديث: 20240910
DOI: 10.1016/j.wneu.2024.06.100
PMID: 38925243
قاعدة البيانات: MEDLINE
الوصف
تدمد:1878-8769
DOI:10.1016/j.wneu.2024.06.100